XBI
XBI
About State Street SPDR S&P Biotech ETF
The State Street SPDR S&P Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index (the "Index")Seeks to provide exposure to the Biotechnology segment of the S&P TMI, which comprises the following sub-industries: BiotechnologySeeks to track a modified equal weighted index...
About State Street SPDR S&P Biotech ETF
The State Street SPDR S&P Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index (the "Index")Seeks to provide exposure to the Biotechnology segment of the S&P TMI, which comprises the following sub-industries: BiotechnologySeeks to track a modified equal weighted index...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 MRNA | Moderna, Inc. | 2.14% | 3.34M | $178.60M |
 ROIV | Roivant Sciences Ltd. | 1.69% | 4.79M | $141.14M |
 PCVX | Vaxcyte, Inc. | 1.66% | 2.23M | $138.34M |
 ACLX | Arcellx, Inc. | 1.63% | 1.16M | $136.50M |
 RVMD | Revolution Medicines, Inc. | 1.57% | 1.24M | $131.52M |
 PRAX | Praxis Precision Medicines, Inc. | 1.56% | 370.26K | $130.50M |
 FOLD | Amicus Therapeutics, Inc. | 1.46% | 8.21M | $121.80M |
 AMGN | Amgen Inc. | 1.44% | 307.15K | $120.61M |
 GILD | Gilead Sciences, Inc. | 1.42% | 798.32K | $118.81M |
 MIRM | Mirum Pharmaceuticals, Inc. | 1.39% | 1.21M | $115.91M |
 KRYS | Krystal Biotech, Inc. | 1.38% | 404.10K | $115.61M |
 BMRN | BioMarin Pharmaceutical Inc. | 1.37% | 1.80M | $114.12M |
 HALO | Halozyme Therapeutics, Inc. | 1.33% | 1.55M | $110.78M |
 CELC | Celcuity Inc. | 1.31% | 951.33K | $109.43M |
 VRTX | Vertex Pharmaceuticals Incorporated | 1.30% | 217.88K | $108.29M |
 EXEL | Exelixis, Inc. | 1.29% | 2.36M | $108.12M |
 ALKS | Alkermes plc | 1.29% | 3.38M | $107.67M |
 CRSP | CRISPR Therapeutics AG | 1.29% | 1.68M | $107.53M |
 REGN | Regeneron Pharmaceuticals, Inc. | 1.27% | 133.37K | $106.42M |
 BIIB | Biogen Inc. | 1.27% | 545.59K | $106.19M |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States
United Kingdom
Ireland
Switzerland
NetherlandsSECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States United Kingdom Ireland Switzerland NetherlandsHoldings (Top 20)
MRNA
Moderna, Inc.
ROIV
Roivant Sciences Ltd.
PCVX
Vaxcyte, Inc.
ACLX
Arcellx, Inc.
RVMD
Revolution Medicines, Inc.
PRAX
Praxis Precision Medicines, Inc.
FOLD
Amicus Therapeutics, Inc.
AMGN
Amgen Inc.
GILD
Gilead Sciences, Inc.
MIRM
Mirum Pharmaceuticals, Inc.
KRYS
Krystal Biotech, Inc.
BMRN
BioMarin Pharmaceutical Inc.
HALO
Halozyme Therapeutics, Inc.
CELC
Celcuity Inc.
VRTX
Vertex Pharmaceuticals Incorporated
EXEL
Exelixis, Inc.
ALKS
Alkermes plc
CRSP
CRISPR Therapeutics AG
REGN
Regeneron Pharmaceuticals, Inc.
BIIB
Biogen Inc.